AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 292: L476-L486, 2007. First published November 3, 2006; doi:10.1152/ajplung.00262.2006
1040-0605/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/2/L476    most recent
00262.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by White, N. M.
Right arrow Articles by Kelley, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by White, N. M.
Right arrow Articles by Kelley, T. J.

Altered cholesterol homeostasis in cultured and in vivo models of cystic fibrosis

Nicole M. White,1 Dechen Jiang,2 James D. Burgess,2 Ilya R. Bederman,3 Stephen F. Previs,3 and Thomas J. Kelley1

Departments of 1Pediatrics and Pharmacology, 2Chemistry, and 3Nutrition, Department of Medicine, Case Western Reserve University and Rainbow Babies and Children's Hospital, Cleveland, Ohio

Submitted 13 July 2006 ; accepted in final form 26 October 2006

Determining how the regulation of cellular processes is impacted in cystic fibrosis (CF) is fundamental to understanding disease pathology and to identifying new therapeutic targets. In this study, unesterified cholesterol accumulation is observed in lung and trachea sections obtained from CF patients compared with non-CF tissues, suggesting an inherent flaw in cholesterol processing. An alternate staining method utilizing a fluorescent cholesterol probe also indicates improper lysosomal storage of cholesterol in CF cells. Excess cholesterol is also manifested by a significant increase in plasma membrane cholesterol content in both cultured CF cells and in nasal tissue excised from cftr–/– mice. Impaired intracellular cholesterol movement is predicted to stimulate cholesterol synthesis, a hypothesis supported by the observation of increased de novo cholesterol synthesis in lung and liver of cftr–/– mice compared with controls. Furthermore, pharmacological inhibition of cholesterol transport is sufficient to cause CF-like elevation in cytokine production in wild-type cells in response to bacterial challenge but has no effect in CF cells. These data demonstrate via multiple methods in both cultured and in vivo models that cellular cholesterol homeostasis is inherently altered in CF. This perturbation of cholesterol homeostasis represents a potentially important process in CF pathogenesis.



Address for reprint requests and other correspondence: T. J. Kelley, Dept. of Pediatrics, Case Western Reserve Univ., 833 BRB, 10900 Euclid Ave., Cleveland, OH 44106-4948 (e-mail: tjk12{at}cwru.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. E. Manson, D. A. Corey, N. M. White, and T. J. Kelley
cAMP-mediated regulation of cholesterol accumulation in cystic fibrosis and Niemann-Pick type C cells
Am J Physiol Lung Cell Mol Physiol, November 1, 2008; 295(5): L809 - L819.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.